⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GALT News
Galectin Therapeutics Inc.
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
globenewswire.com
GALT
Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
globenewswire.com
GALT
Form 8-K
sec.gov
GALT
Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology
globenewswire.com
GALT
Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
GALT
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
globenewswire.com
GALT
Form 8-K
sec.gov
GALT
Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.
globenewswire.com
GALT
Form 8-K
sec.gov
GALT
National Survey: Veterinary Professionals See Stem Cell Therapy as a Powerful New Tool for Inflammatory Diseases in Pets
prnewswire.com
GALT